OverviewSuggest Edit

Truveris is a health information technology company that provides management tools to sponsors of prescription benefit plans and payers of claims under these plans. The major prescription benefit sponsors/payers are governments (Federal, State & Local), health insurance companies, self-insured corporations, and unions. The Company's products and services allow these institutions to take control of ballooning pharmaceutical benefits costs, monitor and enforce Prescription Benefits Manager (PBM) contracts, and meet the regulatory compliance requirements of Sarbanes Oxley and Medicare Part D.
HQNew York, US
Employee Ratings3.3
Culture scoreB

Latest Updates

Employees (est.) (May 2020)114(-2%)
Job Openings7

Key People/Management at Truveris

Bryan Birch

Bryan Birch

Chairman, President, and CEO
Leon Greene

Leon Greene

Co-Founder, EVP - Operations
AJ Loiacono

AJ Loiacono

Co-Founder, EVP - Sales & Marketing
Scott McComb Johnson

Scott McComb Johnson

Bertrand Janin

Bertrand Janin

Vp Engineering
Show more

Truveris Office Locations

Truveris has an office in New York
New York, US (HQ)
2 Park Ave 15th Floor
Show all (1)

Truveris Financials and Metrics

Summary Metrics

Founding Date


Truveris total Funding

$54 m

Truveris latest funding size

$25 m

Time since last funding

3 years ago

Truveris investors

Truveris's latest funding round in September 2017 was reported to be $25 m. In total, Truveris has raised $54 m
Show all financial metrics

Truveris Operating Metrics

Truveris's Customers was reported to be 350 in Sep, 2017.
Sep, 2017


Show all operating metrics

Truveris Online and Social Media Presence

Embed Graph

Truveris Company Culture

  • Overall Culture



  • CEO Rating



  • Compensation



Learn more on Comparably

Truveris Blogs

Free Access to PrEP Drugs Promising for HIV Reduction; May Later Impact Pharmacy Benefit Plans

Some recent developments point to good news for wider access to HIV prevention medications for at-risk, non-insured consumers. These same medications will also be more accessible to insured consumers by 2021, and employer pharmacy plan sponsors will be required to pay the costs.  Employe…

New Breakthrough Cystic Fibrosis Drug Promising for Patients, Challenging for Benefit Plans

  The FDA has announced the approval of Trikafta (elexacaftor/ivacaftor/tezacaftor), the first triple combination therapy to treat the most common form of cystic fibrosis. This new drug has the cystic fibrosis (CF) community excited because it is expected to treat 90% of the CF populati…

New Oral Diabetes Drug May Replace Injectables

Novo Nordisk’s Rybelsus was FDA approved today and it is expected to stir up the diabetes market. This is the first oral tablet formulation of semaglutide, which may be better known to you as Ozempic from all the TV commercials with the catchy jingle.
Show more

Truveris Frequently Asked Questions

  • When was Truveris founded?

    Truveris was founded in 2009.

  • Who are Truveris key executives?

    Truveris's key executives are Bryan Birch, Leon Greene and AJ Loiacono.

  • How many employees does Truveris have?

    Truveris has 114 employees.

  • Who are Truveris competitors?

    Competitors of Truveris include Mayoly Spindler, OPHAM and Enseval.

  • Where is Truveris headquarters?

    Truveris headquarters is located at 2 Park Ave 15th Floor, New York.

  • Where are Truveris offices?

    Truveris has an office in New York.

  • How many offices does Truveris have?

    Truveris has 1 office.